FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a novel compound, formula (I) or a pharmaceutically acceptable salt thereof that has the ability to suppress RORγ activity. In formula (I), the radicals and symbols have the meanings indicated in the claims. Present invention also relates to a pharmaceutical composition comprising said compound and a method of treating or preventing a disease using the compound 
(I).
EFFECT: new compound is proposed for the treatment or prevention of diseases such as multiple sclerosis, chronic rheumatoid arthritis, ankylosing spondylitis, systemic erythromatosis, psoriasis, psoriatic arthritis, inflammatory bowel disease or asthma.
12 cl, 8 tbl, 901 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES | 2007 |
|
RU2463292C2 |
| N-ACYL-N'-(PYRIDIN-2-YL)CARBAMIDES AND THEIR ANALOGUES EXHIBITING ANTICANCER AND ANTIPROLIFERATIVE ACTIVITY | 2014 |
|
RU2769607C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
| BENZOIC ACID DERIVATIVES AS PPAR α AND PPAR λ MODULATORS | 2003 |
|
RU2339613C2 |
| NOVEL COMPOUNDS | 2015 |
|
RU2691389C2 |
| 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2655170C2 |
| NOVEL HYDROXY-ESTER DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2734418C2 |
| NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | 2011 |
|
RU2585763C2 |
| SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
